Walder Wyss advised Sleepiz in the completion of Series A financing round

Walder Wyss has acted as advisor to Sleepiz  in the completion of its CHF 4.4 million Series A financing round. The newly raised capital will support Sleepiz expansion of its portfolio to chronic respiratory disease monitoring.

The round was led by Verve Ventures and joined by ZKB and the venture arm of a US health insurance company.

Walder Wyss has acted as advisor to Sleepiz in all legal aspects of the transaction. The team was led by Hubertus Hillerström (partner, corporate/m&a, pictured) and further included Valentine Schnyder (associate, corporate/m&a), Blerina Ahmeti (trainee, corporate/m&a), as well as Leandro Schafer (trainee, Ccorporate/m&a) and Viktoriya Chernaya (trainee, corporate/m&a).

Sleepiz is a Zürich based medtech startup with a mission to provide patient-centric disease management through seamless integration of contactless monitoring into people’s homes.